← Mechanisms of action
CD274
SINGLE PROTEINHomo sapiens
Preferred name: Programmed cell death 1 ligand 1 ChEMBL ↗
Linked proteins
Drugs acting on this target (158)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| 6mw3211 | Antagonist | experimental | mAb | PDL1 |
| abl501 | Antagonist | experimental | mAb | PDL1 |
| abl503 | Antagonist | experimental | mAb | PDL1 |
| ak129 | Antagonist | experimental | mAb | PDL1 |
| asc22 | Antagonist | experimental | mAb | PDL1 |
| atezolizumab (Tecentriq) | Antagonist | approved | mAb | PD-L1 |
| atg-101 | Antagonist | experimental | mAb | PDL1 |
| b1962 | Antagonist | experimental | mAb | PDL1 |
| bj-005 | Antagonist | experimental | mAb | PDL1 |
| bpi-371153 | Antagonist | experimental | Small molecule | PDL1 |
| bpi-421286 | Antagonist | experimental | Small molecule | PDL1 |
| emb-09 | Antagonist | experimental | mAb | PDL1 |
| FS-118 | Antagonist | experimental | mAb | PDL1 |
| FS-222 | Antagonist | experimental | mAb | PDL1 |
| fs222 | Antagonist | experimental | mAb | PDL1 |
| gnc-035 | Antagonist | experimental | mAb | PDL1 |
| gnc-038 | Antagonist | experimental | mAb | PDL1 |
| gnc-039 | Antagonist | experimental | mAb | PDL1 |
| hb0036 | Antagonist | experimental | mAb | PDL1 |
| hlx301 | Antagonist | experimental | mAb | PDL1 |
| ibc-ab002 | Antagonist | experimental | mAb | PDL1 |
| IBI 323 | Antagonist | experimental | mAb | PDL1 |
| ibi-322 | Antagonist | experimental | mAb | PDL1 |
| ibi323 | Antagonist | experimental | mAb | PDL1 |
| pf-07257876 | Antagonist | experimental | mAb | PDL1 |
| PM-8001 | Antagonist | experimental | mAb | PDL1 |
| pm8002 | Antagonist | experimental | mAb | CD274 antagonist |
| prs-344 | Antagonist | experimental | mAb | PDL1 |
| q-1802 | Antagonist | experimental | mAb | PDL1 |
| qlf31907 | Antagonist | experimental | mAb | PDL1 |
| qlf32004 | Antagonist | experimental | mAb | PDL1 |
| qls31901 | Antagonist | experimental | mAb | PDL1 |
| s095012 | Antagonist | experimental | mAb | PDL1 |
| TQ-B2858 | Antagonist | experimental | mAb | PDL1 |
| tqb2450 | Antagonist | experimental | mAb | PDL1 |
| tqb2858 | Antagonist | experimental | Recombinant protein | CD274 antagonist |
| dcr-pdl1 | Antisense inhibitor | experimental | Nucleic acid | CD274 antisense inhibitor |
| bintrafusp alfa | Binding agent | experimental | Recombinant protein | Programmed cell death 1 ligand 1 binding agent |
| cs1001 | Binding agent | experimental | mAb | Programmed cell death 1 ligand 1 binding agent |
| envafolimab | Binding agent | experimental | mAb | Programmed cell death 1 ligand 1 binding agent |
| sgn-pdl1v | Binding agent | experimental | mAb | PDL1 |
| b7-1 | Immunity, active | experimental | Vaccine | CD274 immunity, active |
| ido peptide | Immunity, active | experimental | Vaccine | CD274 immunity, active |
| mrna-4359 | Immunity, active | experimental | Vaccine | CD274 immunity, active |
| pd-l1 peptide vaccine | Immunity, active | experimental | Vaccine | CD274 immunity, active |
| pd-l1/ido peptide vaccine | Immunity, active | experimental | Vaccine | CD274 immunity, active |
| pd-l2 and pd-l1 peptide | Immunity, active | experimental | Vaccine | CD274 immunity, active |
| dual-targeting cldn18.2 and pd-l1 car-t cells | Immunity, passive | experimental | Cell therapy | CD274 immunity, passive |
| mgd013 | Immunity, passive | experimental | mAb | CD274 immunity, passive |
| pd-1-m1-nk cells | Immunity, passive | experimental | Cell therapy | CD274 immunity, passive |
| pd-l1 car-t cell | Immunity, passive | experimental | Cell therapy | CD274 immunity, passive |
| pd1-til | Immunity, passive | experimental | Cell therapy | CD274 immunity, passive |
| tqb2450 | Immunity, passive | experimental | mAb | CD274 immunity, passive |
| α-pd-l1/4-1bb dll3 car-t (bhp01) | Immunity, passive | experimental | Cell therapy | CD274 immunity, passive |
| 89zr˗dfo˗regn3504 | Inhibitor | experimental | mAb | CD274 inhibitor |
| abs-201 | Inhibitor | experimental | mAb | CD274 inhibitor |
| absk043 | Inhibitor | experimental | Small molecule | CD274 inhibitor |
| adebrelimab | Inhibitor | experimental | Small molecule | CD274 inhibitor |
| ai-081 | Inhibitor | experimental | mAb | CD274 inhibitor |
| an4005 | Inhibitor | experimental | Small molecule | CD274 inhibitor |
| ap203 | Inhibitor | experimental | mAb | CD274 inhibitor |
| ap505 | Inhibitor | experimental | mAb | CD274 inhibitor |
| asc61 | Inhibitor | experimental | Small molecule | CD274 inhibitor |
| atezolizumab (Tecentriq) | Inhibitor | approved | mAb | CD274 inhibitor |
| avelumab (bavencio) | Inhibitor | approved | mAb | CD274 inhibitor |
| axn-2510 | Inhibitor | experimental | mAb | CD274 inhibitor |
| bcd-135 | Inhibitor | experimental | mAb | CD274 inhibitor |
| bgb-a333 | Inhibitor | experimental | mAb | CD274 inhibitor |
| bh3120 | Inhibitor | experimental | mAb | CD274 inhibitor |
| bintrafusp alfa | Inhibitor | experimental | Recombinant protein | CD274 inhibitor |
| bms-936559 | Inhibitor | experimental | mAb | CD274 inhibitor |
| bms-986189 | Inhibitor | experimental | Peptide | CD274 inhibitor |
| BMS-986192 | Inhibitor | experimental | mAb | CD274 inhibitor |
| bnt327 | Inhibitor | experimental | mAb | CD274 inhibitor |
| bpb-101 | Inhibitor | experimental | mAb | CD274 inhibitor |
| ca-170 | Inhibitor | experimental | Small molecule | CD274 inhibitor |
| cn202 | Inhibitor | experimental | mAb | CD274 inhibitor |
| compound 2055269 | Inhibitor | experimental | mAb | CD274 inhibitor |
| cosibelimab (Unloxcyt) | Inhibitor | approved | mAb | Programmed cell death 1 ligand 1 inhibitor |
| cs1001 | Inhibitor | experimental | mAb | CD274 inhibitor |
| ctx-8371 | Inhibitor | experimental | mAb | CD274 inhibitor |
| cvl006 | Inhibitor | experimental | mAb | CD274 inhibitor |
| cx-072 | Inhibitor | experimental | mAb | CD274 inhibitor |
| db-1419 | Inhibitor | experimental | mAb | CD274 inhibitor |
| dk222 | Inhibitor | experimental | Peptide | CD274 inhibitor |
| dr30206 | Inhibitor | experimental | mAb | CD274 inhibitor |
| durvalumab (imfinzi) | Inhibitor | approved | mAb | CD274 inhibitor |
| engineered erythrocytes (or red blood cells) covalently conjugated with commercially available anti-pd-1 antibodies on their membranes | Inhibitor | experimental | Cell therapy | CD274 inhibitor |
| envafolimab | Inhibitor | experimental | mAb | CD274 inhibitor |
| es101 | Inhibitor | experimental | mAb | CD274 inhibitor |
| Evixapodlin | Inhibitor | experimental | Small molecule | CD274 inhibitor |
| faz053 | Inhibitor | experimental | mAb | CD274 inhibitor |
| fs118 | Inhibitor | experimental | mAb | CD274 inhibitor |
| gen1046 | Inhibitor | experimental | mAb | CD274 inhibitor |
| gen1056 | Inhibitor | experimental | mAb | CD274 inhibitor |
| gr1405 | Inhibitor | experimental | mAb | CD274 inhibitor |
| gx-p1 | Inhibitor | experimental | mAb | CD274 inhibitor |
| hb0025 | Inhibitor | experimental | mAb | CD274 inhibitor |
| hb0028 | Inhibitor | experimental | mAb | CD274 inhibitor |
| hcb301 | Inhibitor | experimental | Recombinant protein | CD274 inhibitor |
| hlx20 | Inhibitor | experimental | mAb | CD274 inhibitor |
| hlx37 | Inhibitor | experimental | mAb | CD274 inhibitor |
| hlx43 | Inhibitor | experimental | mAb | CD274 inhibitor |
| hy05350 | Inhibitor | experimental | mAb | CD274 inhibitor |
| hy07121 | Inhibitor | experimental | mAb | CD274 inhibitor |
| ibi-322 | Inhibitor | experimental | mAb | CD274 inhibitor |
| ibi3014 | Inhibitor | experimental | mAb | CD274 inhibitor |
| ibi318 | Inhibitor | experimental | mAb | CD274 inhibitor |
| igm-7354 | Inhibitor | experimental | mAb | CD274 inhibitor |
| imc001 | Inhibitor | experimental | mAb | CD274 inhibitor |
| imgs-001 | Inhibitor | experimental | mAb | CD274 inhibitor |
| imm2510 | Inhibitor | experimental | Recombinant protein | CD274 inhibitor |
| imm2520 | Inhibitor | experimental | mAb | CD274 inhibitor |
| IMMH-010 | Inhibitor | experimental | Small molecule | CD274 inhibitor |
| inbrx-105 | Inhibitor | experimental | mAb | CD274 inhibitor |
| incb086550 | Inhibitor | experimental | Small molecule | CD274 inhibitor |
| incb099280 | Inhibitor | experimental | Small molecule | CD274 inhibitor |
| ivocizumab | Inhibitor | experimental | mAb | CD274 inhibitor |
| jskn022 | Inhibitor | experimental | mAb | CD274 inhibitor |
| kd033 | Inhibitor | experimental | Recombinant protein | CD274 inhibitor |
| kl-a167 | Inhibitor | experimental | mAb | CD274 inhibitor |
| kn046 | Inhibitor | experimental | mAb | CD274 inhibitor |
| lb101 | Inhibitor | experimental | mAb | CD274 inhibitor |
| lbl-024 | Inhibitor | experimental | Small molecule | CD274 inhibitor |
| ldp | Inhibitor | experimental | mAb | CD274 inhibitor |
| lp002 | Inhibitor | experimental | mAb | CD274 inhibitor |
| ly3300054 | Inhibitor | experimental | mAb | CD274 inhibitor |
| ly3415244 | Inhibitor | experimental | mAb | CD274 inhibitor |
| ly3434172 | Inhibitor | experimental | mAb | CD274 inhibitor |
| max-10181 | Inhibitor | experimental | Small molecule | CD274 inhibitor |
| mcla-145 | Inhibitor | experimental | mAb | CD274 inhibitor |
| mdx1105-01 | Inhibitor | experimental | mAb | CD274 inhibitor |
| msb0011359c | Inhibitor | experimental | mAb | CD274 inhibitor |
| msb2311 | Inhibitor | experimental | mAb | CD274 inhibitor |
| mt-6402 | Inhibitor | experimental | Recombinant protein | CD274 inhibitor |
| nm21-1480 | Inhibitor | experimental | mAb | CD274 inhibitor |
| ose-279 | Inhibitor | experimental | mAb | CD274 inhibitor |
| pd-l1/ctla4 bsab | Inhibitor | experimental | mAb | CD274 inhibitor |
| pf-08046037 | Inhibitor | experimental | mAb | CD274 inhibitor |
| pf-08046054 | Inhibitor | experimental | mAb | CD274 inhibitor |
| pm1003 | Inhibitor | experimental | mAb | CD274 inhibitor |
| pm1022 | Inhibitor | experimental | mAb | CD274 inhibitor |
| rc198 | Inhibitor | experimental | mAb | CD274 inhibitor |
| sctb14 | Inhibitor | experimental | mAb | CD274 inhibitor |
| sh006 | Inhibitor | experimental | mAb | CD274 inhibitor |
| shr-1701 | Inhibitor | experimental | Recombinant protein | CD274 inhibitor |
| sim0237 | Inhibitor | experimental | mAb | CD274 inhibitor |
| soa101 | Inhibitor | experimental | mAb | CD274 inhibitor |
| spx-303 | Inhibitor | experimental | mAb | CD274 inhibitor |
| ssgj-706 | Inhibitor | experimental | mAb | CD274 inhibitor |
| ssgj-707 | Inhibitor | experimental | mAb | CD274 inhibitor |
| tagitanlimab | Inhibitor | experimental | mAb | CD274 inhibitor |
| tg-1501 | Inhibitor | experimental | mAb | CD274 inhibitor |
| xb628 | Inhibitor | experimental | mAb | CD274 inhibitor |
| Y101D | Inhibitor | experimental | mAb | CD274 inhibitor |
| zkab001 | Inhibitor | experimental | mAb | CD274 inhibitor |
| avelumab (bavencio) | Other | approved | mAb | CD274 other |
| [68ga]ga-nota-rnd20 | Radiopharmaceutical | experimental | Small molecule | CD274 radiopharmaceutical |